AXGN Axogen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AXGN

Price (delayed)

$6.55

Market cap

$281.94M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.56

Enterprise value

$316.11M

Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore ...

Highlights
Axogen's net income has increased by 19% YoY
The company's EPS rose by 16% YoY
Axogen's quick ratio has decreased by 32% YoY and by 11% from the previous quarter
The equity has decreased by 3.6% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.axogeninc.com
Peers: TMO MDT BSX

Key stats

What are the main financial stats of AXGN
Market
Shares outstanding
43.04M
Market cap
$281.94M
Enterprise value
$316.11M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.88
Price to sales (P/S)
1.85
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.08
Earnings
Revenue
$152.25M
EBIT
-$22.29M
EBITDA
-$17.42M
Free cash flow
-$23.17M
Per share
EPS
-$0.56
Free cash flow per share
-$0.54
Book value per share
$2.28
Revenue per share
$3.54
TBVPS
$4.42
Balance sheet
Total assets
$194.63M
Total liabilities
$96.82M
Debt
$71.27M
Equity
$97.81M
Working capital
$60.79M
Liquidity
Debt to equity
0.73
Current ratio
3.28
Quick ratio
2.32
Net debt/EBITDA
-1.96
Margins
EBITDA margin
-11.4%
Gross margin
81.5%
Net margin
-15.3%
Operating margin
-15.7%
Efficiency
Return on assets
-12.1%
Return on equity
-23.6%
Return on invested capital
-10.6%
Return on capital employed
-13.3%
Return on sales
-14.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AXGN stock price

How has the Axogen stock price performed over time
Intraday
1.08%
1 week
11.02%
1 month
73.28%
1 year
-40.18%
YTD
-34.37%
QTD
31%

Financial performance

How have Axogen's revenue and profit performed over time
Revenue
$152.25M
Gross profit
$124.13M
Operating income
-$23.88M
Net income
-$23.24M
Gross margin
81.5%
Net margin
-15.3%
The company's net margin rose by 29% YoY and by 3.8% QoQ
AXGN's operating margin is up by 29% YoY and by 6% QoQ
Axogen's operating income has increased by 19% YoY and by 3.4% from the previous quarter
Axogen's net income has increased by 19% YoY

Growth

What is Axogen's growth rate over time

Valuation

What is Axogen stock price valuation
P/E
N/A
P/B
2.88
P/S
1.85
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.08
The company's EPS rose by 16% YoY
AXGN's P/B is 37% below its 5-year quarterly average of 4.6 and 20% below its last 4 quarters average of 3.6
The equity has decreased by 3.6% YoY
AXGN's P/S is 61% below its 5-year quarterly average of 4.8 and 26% below its last 4 quarters average of 2.5
The revenue has grown by 14% YoY and by 2.9% from the previous quarter

Efficiency

How efficient is Axogen business performance
The company's return on sales rose by 31% YoY and by 7% QoQ
The ROA has increased by 17% YoY
Axogen's return on invested capital has increased by 17% YoY
Axogen's ROE has increased by 14% YoY

Dividends

What is AXGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AXGN.

Financial health

How did Axogen financials performed over time
The total assets is 101% higher than the total liabilities
Axogen's quick ratio has decreased by 32% YoY and by 11% from the previous quarter
AXGN's current ratio is down by 25% year-on-year and by 9% since the previous quarter
The company's debt is 27% lower than its equity
The equity has decreased by 3.6% YoY
The debt to equity has grown by 2.8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.